Bionic Vision Technologies raised $18 million for development and commercialization of its device to restore vision to the blind.

CardioFocus raised $20 million, which will boost the commercialization of its endoscopic ablation system for the treatment of a fib.

Cancer blood test business Biocept has priced shares and warrants worth an anticipated $9.3 million.

Theranos’ board approved a deal to offer more shares to investors who promise not to sue the company, sources told The Wall Street Journal.

AliveCor is launching a new platform to help physicians manage reports from its smartphone ECG recorder.

RenalGuard Solutions raised $14.5 million in a Series A round. The funds will support the pivotal trial of a device that protects the kidneys.

Johnson & Johnson is planning to close a surgical suture production plant, potentially putting 400 people out of work.

Vertiflex closed a $40 million financing round, which will fund the commercial expansion of its minimally invasive spinal stenosis implant in the U.S.

Velano Vascular raised $17 million in financing, which it will put toward scaling and commercializing its line of vascular access devices.